Aeva Technologies: Rezk trust proposes $550K sale
Earlier sales listed include 28,173 shares on November 5, 2026 and a Rule 10b5-1 sale of 100,000 shares on August 10, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Aeva Technologies, Inc. is named as issuer in a Form 144 notice proposing that Rezk Family Trust UAD 02/15/2022 sell 50,000 common shares, with an aggregate market value of $550,000.00 and an approximate sale date of November 9, 2026. The notice gives March 17, 2026 as the plan-adoption or instruction date if relying on Rule 10b5-1, names Morgan Stanley Smith Barney LLC as broker, and reports 69,896,274 common shares outstanding. The relationship-to-issuer fields list Director and Officer; Mina Rezk signed the notice.
The past-three-month sales table lists 28,173 common shares sold on November 5, 2026, for gross proceeds of $248,536.57, and a separately labeled Rule 10b5-1 sale of 100,000 common shares on August 10, 2026, for gross proceeds of $2,401,300.00.
Key Figures
Key Terms
Rule 10b5-1 regulatory
Restricted Stock Units financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.